logo

Kalvista Pharmaceuticals, Inc. (KALV)



Trade KALV now with
  Date
  Headline
9/15/2021 6:16:23 AM KalVista's KOMPLETE View
9/14/2021 6:53:08 AM KalVista: FDA Lifts Clinical Hold On Phase 2 Clinical Trial Of KVD824 For Hereditary Angioedema
8/9/2021 7:17:15 AM KalVista Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7/12/2021 7:41:06 AM KalVista Pharma Presents Phase 2 Data For KVD900 At EAACI Congress
5/3/2021 7:15:55 AM KalVista Pharma Appoints Paul Audhya As Chief Medical Officer